✦ LIBER ✦

Outcomes From Switching From Rotigotine Patch to Alternate Therapies in Parkinson's Disease

✍ Scribed by Chitnis, Shilpa; Jaffery, Manall; Dewey, Richard B.

Book ID: 118050760
Publisher: Informa plc
Year: 2012
Tongue: English
Weight: 165 KB
Volume: 122
Category: Article
ISSN: 0020-7454
DOI: 10.3109/00207454.2011.617016

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

2.247 Safe and tolerable switching from

2.247 Safe and tolerable switching from oral dopaminergic agonists to transdermal rotigotine in Parkinson's disease

✍ P. LeWitt; B. Boroojerdi 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Rotigotine transdermal patch in combinat

Rotigotine transdermal patch in combination therapy for Parkinson’s disease – observations in routine clinical practice

✍ Ceballos-Baumann, Andres; Häck, Hermann-Josef 📂 Article 📅 2011 🏛 Informa plc 🌐 English ⚖ 198 KB

Emerging therapies for Parkinson's disea

Emerging therapies for Parkinson's disease: From bench to bedside

✍ Tarazi, F.I.; Sahli, Z.T.; Wolny, M.; Mousa, S.A. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 580 KB

Rotigotine transdermal patch: a guide to

Rotigotine transdermal patch: a guide to its use in Parkinson’s disease and restless leg syndrome

✍ Lyseng-Williamson, Katherine A.; Sanford, Mark; Scott, Lesley J. 📂 Article 📅 2013 🏛 Adis International Limited (now part of Wolters Kl 🌐 English ⚖ 269 KB

Switching from pergolide to pramipexole

Switching from pergolide to pramipexole in patients with Parkinson's disease

✍ P. A. Hanna; L. Ratkos; W. G. Ondo; J. Jankovic 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 100 KB

From Transplants to Gene Therapy for Par

From Transplants to Gene Therapy for Parkinson's Disease

✍ Thomas B. Freeman 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 44 KB